rs4647992

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003998.4(NFKB1):​c.159+305C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0578 in 152,218 control chromosomes in the GnomAD database, including 283 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.058 ( 283 hom., cov: 32)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.126

Publications

20 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 4-102534190-C-T is Benign according to our data. Variant chr4-102534190-C-T is described in ClinVar as Benign. ClinVar VariationId is 1274917.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0903 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
NM_003998.4
MANE Select
c.159+305C>T
intron
N/ANP_003989.2
NFKB1
NM_001382625.1
c.159+305C>T
intron
N/ANP_001369554.1
NFKB1
NM_001382626.1
c.159+305C>T
intron
N/ANP_001369555.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
ENST00000226574.9
TSL:1 MANE Select
c.159+305C>T
intron
N/AENSP00000226574.4
NFKB1
ENST00000394820.8
TSL:1
c.156+305C>T
intron
N/AENSP00000378297.4
NFKB1
ENST00000505458.5
TSL:1
c.156+305C>T
intron
N/AENSP00000424790.1

Frequencies

GnomAD3 genomes
AF:
0.0578
AC:
8788
AN:
152100
Hom.:
283
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0927
Gnomad AMI
AF:
0.0703
Gnomad AMR
AF:
0.0355
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.0500
Gnomad SAS
AF:
0.0340
Gnomad FIN
AF:
0.0652
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0452
Gnomad OTH
AF:
0.0492
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0578
AC:
8802
AN:
152218
Hom.:
283
Cov.:
32
AF XY:
0.0576
AC XY:
4289
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0928
AC:
3854
AN:
41538
American (AMR)
AF:
0.0354
AC:
541
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3472
East Asian (EAS)
AF:
0.0496
AC:
257
AN:
5184
South Asian (SAS)
AF:
0.0347
AC:
167
AN:
4816
European-Finnish (FIN)
AF:
0.0652
AC:
692
AN:
10608
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0452
AC:
3075
AN:
68010
Other (OTH)
AF:
0.0487
AC:
103
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
428
856
1285
1713
2141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0478
Hom.:
797
Bravo
AF:
0.0584
Asia WGS
AF:
0.0480
AC:
167
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.5
DANN
Benign
0.73
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4647992; hg19: chr4-103455347; API